Remote video-based outcome measures of patients with Parkinson’s disease after deep brain stimulation using smartphones: a pilot study

Abstract

OBJECTIVE To provide better postoperative healthcare for patients with Parkinson’s disease (PD) who received deep brain stimulation (DBS) surgery and to allow surgeons improved tracking of surgical outcomes, the authors sought to examine the applicability and feasibility of remote assessment using smartphones. METHODS A disease management mobile application specifically for PD was used to perform the remote assessment of patients with PD who underwent DBS. Connection with patients was first established via a phone call or a social application, and instructions for completing the remote assessment were delivered. During the video-based virtual meeting, three nonmotor assessment scales measuring the quality of life and mental state, and a modified version of the Movement Disorder Society–sponsored revision of the Unified Parkinson’s Disease Rating Scale, part III (MDS-UPDRS III) measuring motor abilities were evaluated. After the assessment, a report and the satisfaction questionnaire were sent to the patient. RESULTS Overall, 22 patients were recruited over a 4-week period. Among those, 18 patients completed the assessment on the mobile application. The mean duration was 41.3 minutes for video assessment and 17.5 minutes for nonmotor assessment via telephone. The mean estimated cost was 427.68 Chinese yuan (CNY) for an in-person visit and 20.91 CNY for a virtual visit (p < 0.001). The mean time estimate for an in-person visit was 5.51 hours and 0.68 hours for a virtual visit (p = 0.002). All patients reported satisfaction (77.78% very satisfied and 22.22% satisfied) with the virtual visit and were specifically impressed by the professionalism and great attitude of the physician assistant. The majority of patients agreed that the evaluation time was reasonable (50% totally agree, 44.44% agree, and 5.56% neither agree nor disagree) and all patients expressed interest in future virtual visits (61.11% very willingly and 38.89% willingly). No adverse events were observed during the virtual visit. CONCLUSIONS Innovation in remote assessment technologies was highly feasible for its transforming power in the clinical management of patients with PD who underwent DBS and research. Video-based remote assessment offered considerable time and resource reduction for both patients and doctors. It also increased safety and was a well-accepted, favored tool. Finally, the results of this study have shown there is potential to combine remote assessment tools with real-life clinical visits and other telemedical technologies to collectively benefit the postoperative healthcare of patients with PD undergoing DBS.

Remote scoring models of rigidity and postural stability of Parkinson’s disease based on indirect motions and a low-cost RGB algorithm

“…Several studies related to remote vision assessment, removed rigidity, and postural stability since they were hard to achieve in the remote condition (Stillerova et al, 2016;Xu et al, 2021). Instead of directly touching and using pullback test, in our study, by using a machine learning system based on RGB camera and clinical features extracted from the MDS-UPDRS III, we developed four models for estimating rigidity and PS in relation to PD, achieving an accuracy greater than 70%.…”

“…Compared with other wearable sensors, the most available pattern during COVID-19 was using a vision algorithm remotely, since participants did not need to be trained in wearing the sensors and ensuring the accuracy of the process. Moreover, vision-based remote assessment can be a time-saving, resource-saving, well-accepted tool for both patients and doctors (Xu et al, 2021). The red, green, and blue (RGB) color model is one of the most low-cost and widely available methods for online follow-ups since it can be applied through most smartphone cameras.…”

Telemedicine in neurology: advances and possibilities

“…Other studies indicate that telemedicine is a useful tool on the management of patients with dementia 20 - 22 , movement disorders 23 , 24 , including deep brain stimulation (DBS) 25 , 26 follow-up, and in the attention of their caregivers 27 .…”

Parkinson's disease and Covid-19: The effect and use of telemedicine

“…Interestingly, the estimated costs for the remote assessments were 20-fold lower than for in-person visits ( Xu et al, 2021 ). The latter seems to be backed by other studies ( Delgoshaei et al, 2017 ), although this is not consistent with some studies only reporting increased patient satisfaction without a significant cost reduction ( Snoswell et al, 2020 ).…”